| Patents for A61K 31 - Medicinal preparations containing organic active ingredients (785,912) |
|---|
| 07/16/1998 | WO1998030201A1 Use of shogaols and gingerols for preparing deodorant compositions |
| 07/16/1998 | WO1998030197A1 Agent and method for permanently shaping the hair, based on n-branched-chain alkyl-substituted mercapto acetamides and process for their preparation |
| 07/16/1998 | WO1998030171A1 Opiate antagonist implant and process of preparation therefor |
| 07/16/1998 | WO1998030114A1 Method for preparing ginkgo fruit juice |
| 07/16/1998 | WO1998030102A1 Non-iron metalloporphyrins and methods of use |
| 07/16/1998 | WO1998030092A1 Methods for closing suturable wounds by use of cyanoacrylate ester compositions comprising an antimicrobial agent |
| 07/16/1998 | WO1998030091A1 Methods for treating non-suturable, superficial wounds by use of cyanoacrylate ester compositions comprising an antimicrobial agent |
| 07/16/1998 | WO1998030090A1 Cyanoacrylate compositions comprising an antimicrobial agent |
| 07/16/1998 | WO1998024463A3 Combination therapy using a tnf binding protein for treating tnf-mediated diseases |
| 07/16/1998 | WO1998021222A3 1-galactose derivatives |
| 07/16/1998 | WO1998021213A3 2R,4S,R,S- and 2S,4R,R,S-hydroxyitraconazole- and hydroxysaperconazole derivatives |
| 07/16/1998 | WO1998021181A3 15-fluoro prostaglandins as ocular hypotensives |
| 07/16/1998 | WO1998020835A3 Method of treating hyperlipidemia in humans |
| 07/16/1998 | WO1998019998A3 N-substituted 2-cyanopyrrolidines |
| 07/16/1998 | WO1998019674A3 A method for treating tension-type headache |
| 07/16/1998 | WO1998014454A3 (o-ACYL-p-N-ACYLAMINO-PHENYL)-O-PHOSPHOETHANOLAMINES |
| 07/16/1998 | WO1997048672A3 Substituted tetrahydronaphthalene and dihydronaphthalene derivatives having retinoid and/or retinoid antagonist-like biological activity |
| 07/16/1998 | DE19701949A1 Transdermales therapeutisches System Transdermal therapeutic system |
| 07/16/1998 | DE19701059A1 Acetylsalicylsäure enthaltendes transdermales therapeutisches System mit Resorptionsverstärkung Aspirin-containing transdermal therapeutic system with absorption enhancement |
| 07/16/1998 | DE19700913A1 Transdermales therapeutisches System zur Abgabe von Hormonen Transdermal therapeutic system for the delivery of hormones |
| 07/16/1998 | DE19700795A1 Verwendung von Aminothiazolen zur Wund- und Hautbehandlung Use of aminothiazoles for wound and skin treatment |
| 07/16/1998 | CA2317413A1 Cyanoacrylate compositions comprising an antimicrobial agent |
| 07/16/1998 | CA2278159A1 Treatment for cancer and compounds for use therein |
| 07/16/1998 | CA2278158A1 Cytokine related treatments of disease |
| 07/16/1998 | CA2278137A1 Opiate antagonist implant and process of preparation therefor |
| 07/16/1998 | CA2277944A1 Non-immunogenic prodrugs and selectable markers for use in gene therapy |
| 07/16/1998 | CA2277479A1 Use of diadenosine polyphosphates for reducing blood pressure |
| 07/16/1998 | CA2277367A1 Transdermal therapeutic system |
| 07/16/1998 | CA2277220A1 Tablet for the controlled release of active agents |
| 07/16/1998 | CA2277121A1 Macrocyclic inhibitors of matrix metalloproteinases and tnf.alpha. secretion |
| 07/16/1998 | CA2277116A1 Tricyclic erythromycin derivatives |
| 07/16/1998 | CA2277105A1 C-terminal ketone hydroxamic acid inhibitors of matrix metalloproteinases and tnfa secretion |
| 07/16/1998 | CA2276738A1 Vitronectin receptor antagonists |
| 07/16/1998 | CA2276720A1 2-(1,2,4-triazole-1-yl)-1,3,4-thiadiazole derivatives having an effect on the c.n.s. and the heart |
| 07/16/1998 | CA2276525A1 Substituted bis-acridines and related compounds as ccr5 receptor ligands, anti-inflammatory agents and anti-viral agents |
| 07/16/1998 | CA2276483A1 Taxoid reversal agents for drug-resistance in cancer chemotherapy and pharmaceutical compositions thereof |
| 07/16/1998 | CA2275659A1 Photochemotherapeutic compositions |
| 07/16/1998 | CA2275566A1 2,4-diaminopyrimidine compounds as anti-cancer agents |
| 07/16/1998 | CA2272941A1 Attenuation of opioid tolerance by inhibiting inducible nitric oxide synthase pathways in the treatment of pain |
| 07/16/1998 | CA2227159A1 Nucleic acid construct for expressing active substances which can be activated by proteases, and preparation and use |
| 07/15/1998 | EP0853123A1 Purification of DNA by 'cross-flow-filtration' |
| 07/15/1998 | EP0853085A1 Piperidine derivatives having anxiolytic effect |
| 07/15/1998 | EP0853084A2 Substituted purine derivatives as vitronectin receptor antagonists |
| 07/15/1998 | EP0853083A1 Pyridylfuran and pyridylthiophene compounds and pharmaceutical use thereof |
| 07/15/1998 | EP0852951A1 Stable lyophilized monoclonal or polyclonal antibodies containing pharmaceuticals |
| 07/15/1998 | EP0852949A2 Use of alpha-amino-acids for enhancing desmosomal degradation or stratum corneum desquamation |
| 07/15/1998 | EP0852948A1 Use of glycosidase inhibitor for the preparation of a medicament for the prophylaxis or treatment of malaria, endotoxic shock or septic shock |
| 07/15/1998 | EP0852946A2 Composition for cosmetic, pharmaceutical or dietetic use based on an amino-sugar and/or a polyhydroxylic acid |
| 07/15/1998 | EP0852624A2 Glycoprotein b of the rfhv/kshv subfamily of herpes viruses |
| 07/15/1998 | EP0852587A2 Synthetic peptides that inhibit il-6 activity |
| 07/15/1998 | EP0852586A1 Binding protein |
| 07/15/1998 | EP0852585A1 Method for treating alzheimer's disease using glial cell line-derived neurotrophic factor (gdnf) protein product |
| 07/15/1998 | EP0852504A1 Inhibitors of integrin receptors and their therapeutical uses |
| 07/15/1998 | EP0852503A1 Composition for the treatment of diarrhea, its use and its preparation |
| 07/15/1998 | EP0852501A1 Use of hyaluronic acid as an immunosuppressant |
| 07/15/1998 | EP0852500A1 Modified ether glyceroglycolipids |
| 07/15/1998 | EP0852499A1 Therapeutic azide compounds |
| 07/15/1998 | EP0852497A1 Use of prostane derivatives and the combination thereof with antibiotics in the treatment of bacterial infections |
| 07/15/1998 | EP0852496A1 Method for treating a tic disorder |
| 07/15/1998 | EP0852495A1 Pharmaceutical compositions containing hydroximic acid derivatives |
| 07/15/1998 | EP0852494A2 Peripherally active anti-hyperalgesic opiates |
| 07/15/1998 | EP0852491A1 Use of heparinases to decrease inflammatory responses |
| 07/15/1998 | EP0852490A2 Emulsion and micellar formulations for the delivery of biologically active substances to cells |
| 07/15/1998 | EP0852489A1 Hair care composition including at least one silicone polymer grafted by anionic, amphoteric or non-ionic monomers, and at least one amphoteric polymer |
| 07/15/1998 | EP0852486A2 Antiplaque oral composition |
| 07/15/1998 | EP0852469A2 Use of threonine for the treatment of phenylketonuria |
| 07/15/1998 | EP0852467A1 Cancer chemoprotective food products |
| 07/15/1998 | EP0852463A1 Myogenic differentiation of human mesenchymal stem cells |
| 07/15/1998 | EP0719263B1 Heterocyclic carboxamide derivatives with antiarrhythmic activity |
| 07/15/1998 | EP0717746B1 Phosphinic acid derivatives with anti-hyper glycemic and/or anti-obesity activity |
| 07/15/1998 | EP0696190B1 Nasal aromatic releasing compositions |
| 07/15/1998 | EP0681477A4 Genetic modification of neural stem cells. |
| 07/15/1998 | EP0646119B1 Quaternary nitrogen-containing phosphonate compounds for treating abnormal calcium and phosphate metabolism as well as dental calculus and plaque |
| 07/15/1998 | EP0509019B1 Treatment of human retroviral infections with 2',3'-dideoxyinosine |
| 07/15/1998 | CN1187821A Rapamycin derivatives |
| 07/15/1998 | CN1187813A Fatty acid esters as bioactive compounds |
| 07/15/1998 | CN1187812A Indole derivatives as CGMP-PDE inhibitors |
| 07/15/1998 | CN1187811A 1-£omega-(3,4-dihydro-2-naphthalenyl) alkyl| cyclic amine derivatives, process for producing same, and medicinal composition containing same |
| 07/15/1998 | CN1187808A Optically active substituted pheynylalkylamine derivatives |
| 07/15/1998 | CN1187772A Method of preventing or treating allergies |
| 07/15/1998 | CN1187771A Use of nitric oxide-releasing agents to treat imptotency |
| 07/15/1998 | CN1187770A Therapeutic composition for arthritis |
| 07/15/1998 | CN1187769A Lactacystin analogs |
| 07/15/1998 | CN1187768A Combination of 5-HT uptake inhibitor with selective 5-HT1A antagonist |
| 07/15/1998 | CN1187767A Method and formulation for modulating human sexual response |
| 07/15/1998 | CN1187766A Cosmetic make-up compositions |
| 07/15/1998 | CN1187490A 5-membered ring heterocycles as inhibitors of leucocyte adhesion and as VLA-4 antagonists |
| 07/15/1998 | CN1187486A Difluoroprostaglundin Derivatives and their use |
| 07/15/1998 | CN1187352A Medicine composition of saponin containing protopanaxyndiol component and preparing process and application thereof |
| 07/15/1998 | CN1187351A Medicine for curing mastosis |
| 07/15/1998 | CN1187350A Analgesic for osteonosus and osteoarthropathy |
| 07/15/1998 | CN1187349A Medicine for curing diabetes and nephrosis and delaying chronic renal failure |
| 07/15/1998 | CN1039123C Process for preparing 3'-aziridino-anthracycline derivatives and its use |
| 07/15/1998 | CN1039120C N-££1-£4(4-fluorophenoxy) butyl|-4-piperidinyl|-n-methylamino|-2-benzothiazolols as class III antiarr hythmic agents |
| 07/15/1998 | CN1039087C External use medicine for gynecopathy |
| 07/15/1998 | CN1039086C Process for preparing low dose dry pharmaceutical preparations |
| 07/14/1998 | US5780676 Bicyclic benzyl, pyridinyl, thiophene, furanyl, pyrrole, and polyenoic acid derivatives |
| 07/14/1998 | US5780667 Phosphodiesterase-4 and tumor necrosis factor inhibitor |
| 07/14/1998 | US5780658 Process for the synthesis of cationic surfactants comprising esterification with basic character amino acids |
| 07/14/1998 | US5780648 Benzothiophene compounds, and uses formulations thereof |